Sono-Coat
A medical technology company with the mission to improve patient care through innovative visibility solutions for ultrasound-guided interventions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Growth Equity VC | |
| Total Funding | 000k | ||
Related Content
Sono-Coat, an entity within the LipoCoat group, operates as a specialized medical technology firm headquartered in Enschede, Netherlands. The company is focused on enhancing the safety and efficacy of ultrasound-guided interventions through its proprietary echogenic coating systems. This technology is engineered to significantly improve the ultrasound visibility of medical instruments, such as needles and catheters, when used inside a patient's body.
The company's origins trace back to 2005. A pivotal moment in its history occurred in March 2024, when it was strategically acquired by LipoCoat Holdings. This acquisition was supported by a growth investment from 819 Capital Partners, integrating Sono-Coat's visibility solutions with LipoCoat's broader portfolio of bio-inspired surface coatings. The inventor of the core technology and the company's Chief Technology Officer is Lee Ayres, who holds a PhD in Synthetic Polymer Chemistry and has led the development and upscaling of the coating platforms. The leadership team is bolstered by Jasper van Weerd, who serves as CEO of the LipoCoat Group, and Fabian Stein, the Chief Business Development Officer.
Sono-Coat's business model centers on providing its advanced coating services to the MedTech industry, forming long-term partnerships with medical device manufacturers. The technology consists of biocompatible coatings that create a clear, sharp image of the device on an ultrasound screen from any angle. This addresses a critical need for precision in complex procedures like regional anaesthesia, ablation therapies, and various biopsy and drainage operations. The company offers distinct coating series for different materials: the P-series for polymers like Polyurethane and PEEK, and the M-Series for metals such as Steel and Titanium. A clinical study highlighted that a Sono-Coat treated needle outperformed other common echogenic needles in ultrasound visibility, as ranked by a panel of interventional clinicians.
Keywords: echogenic coating, ultrasound visibility, medical device coating, ultrasound guided interventions, needle visualization, catheter visibility, MedTech, medical imaging, regional anesthesia, ablation therapy, biopsy guidance, sonography, interventional radiology, LipoCoat group, 819 Capital Partners, Jasper van Weerd, Lee Ayres, polymer coating, metal coating, biocompatible coating